title: Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
authors.affiliation: Transplant Service, University of California, San Francisco 94143.
authors.forename: J S
authors.initials: JS
authors.lastname: Melzer
authors.forename: R M
authors.initials: RM
authors.lastname: Husing
authors.forename: N J
authors.initials: NJ
authors.lastname: Feduska
authors.forename: S J
authors.initials: SJ
authors.lastname: Tomlanovich
authors.forename: F
authors.initials: F
authors.lastname: Vincenti
authors.forename: W J
authors.initials: WJ
authors.lastname: Amend
authors.forename: M
authors.initials: M
authors.lastname: Garovoy
authors.forename: O
authors.initials: O
authors.lastname: Salvatierra
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D003524:Cyclosporins / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine